Pharma Medica
Alison Lin has a diverse work experience spanning over several years. Alison currently holds the position of Vice President of Clinical Operations at Pharma Medica Research Inc. starting from May 2022. Before that, they worked as the Director of Clinical Operations at BioPharma Services Inc. from January 2019 to September 2020. Alison also has a long history with Pharma Medical Research Inc., where they held various positions such as Manager of Clinical Operations from an unknown start date to December 2018, Associate Manager of Clinical Study from an unknown start date to 2014, Senior Study Coordinator from an unknown start date to 2010, Study Coordinator from an unknown start date to 2008, and Assistant Study Coordinator from an unknown start date to 2006. In addition to their industry experience, Alison also worked as a Research Technician at the University of Toronto, Faculty of Pharmacy from January 2005 to June 2005.
Alison Lin completed their education as follows:
- From 2020 to 2022, they attended the University of Toronto - Rotman School of Management, where they pursued a Global Executive MBA for Healthcare and the Life Sciences in the field of Business Administration and Management.
- Between 2002 and 2004, they obtained a Master's degree in Pharmaceutical Sciences from the University of Toronto.
- From 1997 to 2002, they earned their Bachelor's Degree in Toxicology from the University of Toronto.
There is no information available about any additional certifications Alison Lin may have obtained.
Pharma Medica
Pharma Medica Research Inc is a full service contract research organization based in the greater Toronto area. We focus primarily on phase I, first-in-man, and bioequivalence trials in healthy volunteers, special populations, and patients. By remaining specialized in this area, we have developed true expertise in the field. Our track record speaks for itself we have completed over 1500 clinical trials, been successfully audited by the FDA and EMEA, and helped to bring over 250 drugs to markets. Through an uncompromising commitment to quality and service, a reputation for on-time performance, innovation at all levels, and delivery of services at reasonable costs, we have become trusted partners of many of the worlds leading pharmaceutical companies.